Jwad SM, Al-Fatlawi HY. Types of diabetes and their effect on the immune system[J]. J Adv Pharm Pract. 2022;4:21–30.

Google Scholar 

Kahn BB. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance[J]. Cell. 1998;92(5):593–6.

Article  CAS  PubMed  Google Scholar 

Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract. 2022;183:109119.

Article  PubMed  Google Scholar 

Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review[J]. Clin Exp Ophthalmol. 2016;44(4):260–77.

Article  PubMed  Google Scholar 

Smokovski I. Managing diabetes in low income countries[M]. springer; 2021.

Kane JP, Pullinger CR, Goldfine ID, et al. Dyslipidemia and Diabetes Mellitus: role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus[J]. Curr Opin Pharmacol. 2021;61:21–7.

Article  CAS  PubMed  Google Scholar 

Hong M, Ling Y, Lu Z, et al. Contribution and interaction of the low-density lipoprotein cholesterol to high‐density lipoprotein cholesterol ratio and triglyceride to diabetes in hypertensive patients: a cross‐sectional study[J]. J Diabetes Invest. 2019;10(1):131–8.

Article  CAS  Google Scholar 

Artha IMJR, Bhargah A, Dharmawan NK et al. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus[J]. Vasc Health Risk Manag, 2019: 149–57.

Lokpo SY, Laryea R, Osei-Yeboah J et al. The pattern of dyslipidaemia and factors associated with elevated levels of non-HDL-cholesterol among patients with type 2 diabetes mellitus in the Ho municipality: a cross sectional study[J]. Heliyon, 2022, 8(8).

Achila OO, Fessahye N, Mengistu ST, et al. A community based cross sectional study on the prevalence of dyslipidemias and 10 years cardiovascular risk scores in adults in Asmara, Eritrea[J]. Sci Rep. 2022;12(1):5567.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayoade OG, Umoh I, Amadi C. Dyslipidemia and associated risk factors among nigerians with hypertension[J]. Dubai Med J. 2020;3(4):155–61.

Article  Google Scholar 

Mahmoud I, Sulaiman N. Dyslipidaemia prevalence and associated risk factors in the United Arab Emirates: a population-based study[J]. BMJ open. 2019;9(11):e031969.

Article  PubMed  PubMed Central  Google Scholar 

Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease[J]. Nat Rev Nephrol. 2016;12(2):73–81.

Article  CAS  PubMed  Google Scholar 

Qing G, Deng W, Zhou Y, et al. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and suicidal ideation in adults: a population-based study in the United States[J]. Lipids Health Dis. 2024;23(1):17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wen J, Chen Y, Huang Y, et al. Association of the TG/HDL-C and non-HDL-C/HDL-C ratios with chronic kidney disease in an adult Chinese population[J]. Kidney Blood Press Res. 2018;42(6):1141–54.

Article  Google Scholar 

Lu S, Kuang M, Yue J, et al. Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population[J]. Lipids Health Dis. 2022;21(1):95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang M, Wang M, Zhang R, et al. A combined association of serum uric acid, alanine aminotransferase and waist circumference with non-alcoholic fatty liver disease: a community-based study[J]. PeerJ. 2022;10:e13022.

Article  PubMed  PubMed Central  Google Scholar 

Kim SW, Jee JH, Kim HJ, et al. Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1. Int J Cardiol. 2013;168(3):2678–83. https://doi.org/10.1016/j.ijcard.2013.03.027.

Article  PubMed  Google Scholar 

NCHS Research Ethics Review Board (ERB). Approval. Centers for Disease Control and Prevention (CDC). Accessed June 7, https://www.cdc.gov/nchs/nhanes/irba98.htm.

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of Observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7. https://doi.org/10.1016/s0140-6736(07)61602-x.

Article  Google Scholar 

The association between. Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and risk of depression among US adults: A cross-sectional NHANES study.

American Diabetes Association. Standards of medical care in diabetes–2011. Diabetes Care. 2011;34(Suppl 1):S11–61. https://doi.org/10.2337/dc11-S011.

Article  CAS  PubMed Central  Google Scholar 

Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM et al. National Health and Nutrition Examination Survey: Analytic Guidelines, 1999–2010. Vital Health Stat 2. (2013) 161):1–24.

Han M, Li Q, Qie R, et al. Association of non-HDL-C/HDL-C ratio and its dynamic changes with incident type 2 diabetes mellitus: the rural Chinese cohort Study[J]. J Diabetes Complicat. 2020;34(12):107712.

Article  Google Scholar 

Sheng G, Kuang M, Yang R, et al. Evaluation of the value of conventional and unconventional lipid parameters for predicting the risk of diabetes in a non-diabetic population[J]. J Translational Med. 2022;20(1):266.

Article  CAS  Google Scholar 

Zhang N, Hu X, Zhang Q, et al. Non-high‐density lipoprotein cholesterol: high‐density lipoprotein cholesterol ratio is an independent risk factor for diabetes mellitus: results from a population‐based cohort study: [J]. J Diabetes. 2018;10(9):708–14.

Article  CAS  PubMed  Google Scholar 

Mo Z, Han Y, Cao C, et al. Association between non-high-density lipoprotein to high-density lipoprotein ratio and reversion to normoglycemia in people with impaired fasting glucose: a 5-year retrospective cohort study[J]. Volume 15. Diabetology & Metabolic Syndrome; 2023. p. 259. 1.

Hsu SHJ, Jang MH, Torng PL, et al. Positive association between small dense low-density lipoprotein cholesterol concentration and biomarkers of inflammation, thrombosis, and prediabetes in non-diabetic adults[J]. J Atheroscler Thromb. 2019;26(7):624–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schulze MB, Shai I, Manson JE, et al. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes[J]. Diabetologia. 2004;47:2129–36.

Article  CAS  PubMed  Google Scholar 

Ishibashi T, Kaneko H, Matsuoka S, et al. HDL cholesterol and clinical outcomes in diabetes mellitus[J]. Eur J Prev Cardiol. 2023;30(8):646–53.

Article  PubMed  Google Scholar 

Cohn G, Valdes G, Capuzzi DM. Pathophysiology and treatment of the dyslipidemia of insulin resistance[J]. Curr Cardiol Rep. 2001;3(5):416–23.

Article  CAS  PubMed  Google Scholar 

Wang Q, Jiang L, Wang J, et al. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor‐deficient mice[J]. Hepatology. 2009;49(4):1166–75.

Article  CAS  PubMed  Google Scholar 

Zhu R, Liu H, Liu C, et al. Cinnamaldehyde in diabetes: a review of pharmacology, pharmacokinetics and safety[J]. Pharmacol Res. 2017;122:78–89.

Article  CAS  PubMed  Google Scholar 

Sajuthi SP, Sharma NK, Comeau ME, et al. Genetic regulation of adipose tissue transcript expression is involved in modulating serum triglyceride and HDL-cholesterol[J]. Gene. 2017;632:50–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhen R, Ban J, Jia Z et al. The relationship between non-HDL-C/HDL-C ratio (NHHR) and vitamin D in type 2 diabetes mellitus[J]. Diabetes Metabolic Syndrome Obes, 2023: 2661–73.

Manell H, Kristinsson H, Kullberg J, et al. Hyperglucagonemia in youth is associated with high plasma free fatty acids, visceral adiposity, and impaired glucose tolerance[J]. Pediatr Diabetes. 2019;20(7):880–91.

Article  CAS  PubMed  Google Scholar 

Benito-Vicente A, Jebari-Benslaiman S, Galicia-Garcia U, et al. Molecular mechanisms of lipotoxicity-induced pancreatic β-cell dysfunction[J]. Int Rev Cell Mol Biology. 2021;359:357–402.

Article  CAS  Google Scholar 

Narvaez CJ, Simmons KM, Brunton J, et al. Induction of STEAP 4 correlates with 1, 25-dihydroxyvitamin D3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue[J]. J Cell Physiol. 2013;228(10):2024–36.

Article  CAS  PubMed  Google Scholar 

Darenskaya MA, Kolesnikova LI, Kolesnikov SI. Oxidative stress: pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction[J]. Bull Exp Biol Med. 2021;171(2):179–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paul R, Choudhury A, Choudhury S, et al. Cholesterol in pancreatic β-cell death and dysfunction: underlying mechanisms and pathological implications[J]. Pancreas. 2016;45(3):317–24.

Article  CAS  PubMed  Google Scholar 

You SF, Zheng JY, Chen YP, et al. Research progress on the mechanism of beta-cell apoptosis in type 2 diabetes mellitus[J]. Front Endocrinol. 2022;13:976465.

Article  Google Scholar 

Yang T, Liu Y, Li L, et al. Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China[J]. Cardiovasc Diabetol. 2022;21(1):93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuge H, Okada H, Hamaguchi M, et al. Triglycerides/HDL cholesterol ratio and type 2 diabetes incidence: Panasonic Cohort Study 10[J]. Cardiovasc Diabetol. 2023;22(1):308.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Young KA, Maturu A, Lorenzo C, et al. The triglyceride to high-density lipopr